Sabine J. Straus

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data.

European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data.

Journal: British journal of clinical pharmacology

Published: October 17, 2025

Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics.

Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics.

Journal: ACS pharmacology & translational science

Published: June 25, 2025

Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study.

Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study.

Journal: Drug safety

Published: March 31, 2025

Meningococcal B Vaccines as a Paradigm of Safe and Effective Vaccines for Children.

Meningococcal B Vaccines as a Paradigm of Safe and Effective Vaccines for Children.

Journal: Vaccines

Published: February 26, 2025

Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.

Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.

Journal: Clinical pharmacology and therapeutics

Published: December 05, 2024

Commentary/Response to Damkier et al.

Commentary/Response to Damkier et al.

Journal: Pharmacoepidemiology and drug safety

Published: October 31, 2024

Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.

Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.

Journal: Clinical pharmacology and therapeutics

Published: September 13, 2024

The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System.

The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System.

Journal: Drug safety

Published: May 29, 2024

COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance.

COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance.

Journal: Drug safety

Published: March 20, 2024

The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.

The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.

Journal: Drug safety

Published: February 04, 2024

Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations.

Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations.

Journal: Pharmacoepidemiology and drug safety

Published: January 12, 2024

Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases.

Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases.

Journal: Clinical pharmacology and therapeutics

Published: January 11, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026